Journal
CEPHALALGIA
Volume 40, Issue 5, Pages 503-516Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0333102419883355
Keywords
Migraine; episodic migraine; chronic migraine; risk factor; predictor; meta-analysis; systematic review
Categories
Funding
- Allergan
- Amgen
- Avanir
- Biohaven
- Lilly
- Promeius
- Teva
Ask authors/readers for more resources
Background and purpose An estimated 2.5-3.1% of people with episodic migraine develop chronic migraine in a year. Several risk factors are associated with an increased risk for this transformation. We conducted a systematic review and meta-analysis to provide quantitative and qualitative data on predictors of this transformation. Methods An electronic search was conducted for published, prospective, cohort studies that reported risk factors for chronic migraine among people with episodic migraine. Risk of bias was assessed using the Newcastle-Ottawa Quality Assessment Scale. Quality of evidence was determined according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. Effect estimates were retrieved and summarized using risk ratios. Results Of 5695 identified publications, 11 were eligible for inclusion. The pooled analysis (GRADE system) found high evidence for monthly headache day frequency >= 10 (risk ratio = 5.95), moderate evidence for depression (risk ratio = 1.58), monthly headache day frequency >= 5 (risk ratio = 3.18), and annual household income >= $50,000 (risk ratio = 0.65) and very low evidence for allodynia (risk ratio = 1.40) and medication overuse (risk ratio = 8.82) in predicting progression to chronic migraine. Conclusions High frequency episodic migraine and depression have high quality evidence as predictors of the transformation from episodic migraine to chronic migraine, while annual household income over $50,000 may be protective.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available